|
|
Volumn 32, Issue 2, 2009, Pages 89-93
|
|
Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease
a,d
|
|
Author keywords
Adverse effects; Apomorphine; Dopaminergic agonist; Motor fluctuations; Parkinson disease
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALBUMIN;
ALKALINE PHOSPHATASE;
AMANTADINE;
APOMORPHINE;
ASPARTATE AMINOTRANSFERASE;
BICARBONATE;
BILIRUBIN;
BROMOCRIPTINE;
CALCIUM;
CARBIDOPA PLUS LEVODOPA;
CHLORIDE;
CHOLESTEROL;
CREATININE;
GLUCOSE;
HEMOGLOBIN;
IMMUNOGLOBULIN;
LACTATE DEHYDROGENASE;
LEVODOPA;
PERGOLIDE;
PHOSPHORUS;
POTASSIUM;
PRAMIPEXOLE;
PROTEIN;
ROPINIROLE;
SODIUM;
TRIACYLGLYCEROL;
TRIMETHOBENZAMIDE;
UNINDEXED DRUG;
URIC ACID;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ANEMIA;
ARTHRALGIA;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
ASPIRATION PNEUMONIA;
BACKACHE;
BASAL CELL CARCINOMA;
BICARBONATE BLOOD LEVEL;
BILIRUBIN BLOOD LEVEL;
BRADYCARDIA;
CALCIUM BLOOD LEVEL;
CHLORIDE BLOOD LEVEL;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFUSION;
CONGESTIVE HEART FAILURE;
CONSCIOUSNESS;
CORONARY ARTERY DISEASE;
CREATININE BLOOD LEVEL;
DEHYDRATION;
DEPRESSION;
DISEASE SEVERITY;
DIZZINESS;
DRUG DOSE TITRATION;
DRUG EXPOSURE;
DRUG SAFETY;
DRUG WITHDRAWAL;
DYSARTHRIA;
DYSKINESIA;
ECCHYMOSIS;
ELECTROCARDIOGRAM;
EOSINOPHIL COUNT;
ERYTHROCYTE COUNT;
FALLING;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE URINE LEVEL;
HALLUCINATION;
HEADACHE;
HEART ARREST;
HEART ATRIUM FIBRILLATION;
HEART ATRIUM FLUTTER;
HEMATOCRIT;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
INJECTION SITE CONTUSION;
INJECTION SITE REACTION;
INSOMNIA;
KETONURIA;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LEG EDEMA;
LETHARGY;
LIMB PAIN;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MOOD DISORDER;
MUSCULOSKELETAL PAIN;
NAUSEA;
OPEN STUDY;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
PERSONALITY DISORDER;
PHOSPHATE BLOOD LEVEL;
PNEUMONIA;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN URINE LEVEL;
PSYCHOSIS;
SEDATION;
SIDE EFFECT;
SINUS ARREST;
SODIUM BLOOD LEVEL;
SOMNOLENCE;
SYNCOPE;
THORAX PAIN;
THROMBOCYTE COUNT;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
UREA NITROGEN BLOOD LEVEL;
URIC ACID BLOOD LEVEL;
URINARY TRACT INFECTION;
VOMITING;
YAWNING;
ACCIDENTAL FALLS;
AGED;
ANTIPARKINSON AGENTS;
APOMORPHINE;
DRUG ADMINISTRATION SCHEDULE;
ELECTROCARDIOGRAPHY;
FEMALE;
HEART RATE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 67749095108
PISSN: 03625664
EISSN: None
Source Type: Journal
DOI: 10.1097/WNF.0b013e31816d91f9 Document Type: Article |
|
Times cited : (43)
|
|
References (13)
|
